Order Article Reprints

Alwisi N, Ismail R, Al-Kuwari H, Al-Ansari KH, Al-Matwi MA, Aweer NA, Al-Marri WN, Al-Kubaisi Y, Al-Mohannadi M, Hamran S, et al. Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines. 2025; 13(3):702. https://doi.org/10.3390/biomedicines13030702

Alwisi, Nouran, Rana Ismail, Hissa Al-Kuwari, Khalifa H. Al-Ansari, Mohammed A. Al-Matwi, Noor A. Aweer, Wejdan N. Al-Marri, Yousif Al-Kubaisi, Muneera Al-Mohannadi, Shahd Hamran, and et al. 2025. "Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis" Biomedicines 13, no. 3: 702. https://doi.org/10.3390/biomedicines13030702

Alwisi, N., Ismail, R., Al-Kuwari, H., Al-Ansari, K. H., Al-Matwi, M. A., Aweer, N. A., Al-Marri, W. N., Al-Kubaisi, Y., Al-Mohannadi, M., Hamran, S., Doi, S. A. R., Farooqui, H. H., & Chivese, T. (2025). Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines, 13(3), 702. https://doi.org/10.3390/biomedicines13030702